Skip to main content
OpenTrials
Completed

NCT Number: NCT04069416

Salvage Living Donor Liver Transplantation for HCC Beyond All Criteria Yield Equivalent Results to Milan Criteria

The present study aims to evaluate the impact of expanding criteria beyond Milan on tumor recurrence and patient survival that will help identify the best selection criteria for HCC transplanted patients.

Completed

Looking for future studies?

Notify Me

Key information

About this study

Introduction:

HEPATOCELLULAR CARCINOMA (HCC) is the second leading cause of cancer mortality worldwide. Living donor liver transplantation (LDLT) for HCC patients has emerged as a rewarding therapy for a cure and a successful alternative where a Deceased donor liver transplantation (DDLT) program is lacking. Therefore, trials for careful expansion to Milan criteria have been adopted.

Aim of the study:

To evaluate the impact of expanding criteria beyond Milan on tumor recurrence and patient survival that will help identify the best selection criteria for HCC transplanted patients

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All patient transplanted for HCC eligible for transplant (no vascular invasion-no extra hepatic metastasis)
  • age>18y

Exclusion criteria

  • other etiology for liver transplant rather than HCC
  • patient not fit for surgery
  • age >70y

Treatment and study plan

Living donor liver transplantation

Procedure

liver graft from a living donor

Primary outcomes

  1. HCC recurrence

    Time frame: 3 years

    Recurrence of Hepatocellular carcinoma either intra-hepatic, extra-hepatic or both

Sponsors and collaborators

Lead sponsor

Ain Shams University

Other

Registry information

Official study title

Salvage Living Donor Liver Transplantation for HCC Beyond All Criteria Yield Equivalent Results to Milan Criteria in High Prevalence Young HCC Patients Country.

Important dates

Study start
2004
Primary completion
2015
Study completion
2019
First posted
Aug 28, 2019
Registry last updated
Aug 28, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.